glp-1 compound news Drugs from the Gray Market Compound versions of GLP-1 drugs

According to clinical pharmacology research, delayed gastric emptying can significantly alter pharmacokinetics in certain populations

Patients and plaintiffs lawyers argue that Novo Nordisk failed to warn prescribing physicians and patients about the risks of delayed gastric emptying and other serious side effects

Marzook A, Tomas A, Jones B

Follow and Subscribe LinkedIn | Instagram | Webinars | Podcasts

When restless legs syndrome is caused by another disease or condition, or is a side effect of certain medications, the disorder is known as secondary RLS

While the ability of GLP-1 and its stable analogues, exendin-4 (EX4) for example, to reduce food intake is well established, the brain mechanisms governing GLP-1 receptor (GLP-1R)-induced anorexia are still poorly understood